Published in Clin J Am Soc Nephrol on March 05, 2008
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol (2013) 1.46
Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis (2014) 1.35
Lesions of the Seminal Vesicles and their MRI Characteristics. J Clin Imaging Sci (2014) 1.10
Stimulation of human damaged sperm motility with hydrogen molecule. Med Gas Res (2015) 1.05
Sperm status regulates sexual attraction in Caenorhabditis elegans. Genetics (2011) 1.00
Educational paper: ciliopathies. Eur J Pediatr (2011) 0.90
Polycystic diseases in visceral organs. Obstet Gynecol Int (2011) 0.79
Pkd1 is required for male reproductive tract development. Mech Dev (2013) 0.79
Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition. Kidney Int (2016) 0.77
Polycystic horseshoe kidney. Clin Kidney J (2013) 0.75
Novel roles of Pkd2 in male reproductive system development. Differentiation (2014) 0.75
Case study: polycystic livers in a transgenic mouse line. Comp Med (2014) 0.75
Physical deformities relevant to male infertility. Nat Rev Urol (2012) 0.75
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet (2003) 13.33
Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73
A flagellar polycystin-2 homolog required for male fertility in Drosophila. Curr Biol (2003) 1.56
Autosomal dominant polycystic kidney disease--more than a renal disease. Am J Kidney Dis (1990) 1.53
PKD2 cation channel is required for directional sperm movement and male fertility. Curr Biol (2003) 1.23
Polycystin-2 associates with the polycystin-1 homolog, suREJ3, and localizes to the acrosomal region of sea urchin spermatozoa. Mol Reprod Dev (2004) 1.05
The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1998) 0.97
Prevalence of epididymal, seminal vesicle, prostate, and testicular cysts in autosomal dominant polycystic kidney disease. Urology (2002) 0.96
Multicystic epididymes and seminal vesicles in a patient with polycystic kidney disease. Br J Urol (1995) 0.93
Infertility treatment in autosomal dominant polycystic kidney disease (ADPKD)--a case report. Andrologia (2000) 0.93
Immotile cilia syndrome associated with polycystic kidney. J Urol (1984) 0.90
Polycystins: what polycystic kidney disease tells us about sperm. Mol Reprod Dev (2004) 0.90
Clinical relevance of scrotal and transrectal ultrasonography in andrological patients. Int J Androl (1995) 0.89
Assisted reproduction for infertile patients with 9 + 0 immotile spermatozoa associated with autosomal dominant polycystic kidney disease. Hum Reprod (1999) 0.86
Seminal megavesicles with adult polycystic kidney disease. Hum Reprod (1998) 0.84
Male infertility and adult polycystic kidney disease are associated with necrospermia. Fertil Steril (2003) 0.82
[Seminal vesicle cysts and infertility in autosomal dominant polycystic kidney disease]. Nefrologia (2005) 0.80
Polycystic kidney disease and infertility. Fertil Steril (1995) 0.80
Infertility in adults with polycystic kidney disease. Nephrol Dial Transplant (2003) 0.80
Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res (2010) 2.23
Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol (2008) 2.04
Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int (2009) 1.88
DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. J Urol (2009) 1.59
Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol (2010) 1.52
Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU Int (2012) 1.50
Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol (2011) 1.47
[Albuminuria: beyond the kidney]. Med Clin (Barc) (2008) 1.38
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant (2009) 1.21
Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol (2006) 1.14
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol (2010) 1.03
Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases. Am J Kidney Dis (2003) 1.00
NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hum Mutat (2013) 0.95
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2013) 0.95
Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples. Am J Kidney Dis (2007) 0.95
Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer. Eur Urol (2006) 0.94
High resolution X chromosome-specific array-CGH detects new CNVs in infertile males. PLoS One (2012) 0.94
DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol (2013) 0.89
Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet (2007) 0.89
Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome. Hepatology (2006) 0.89
Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. Nephrol Dial Transplant (2004) 0.88
Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. J Urol (2010) 0.87
Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer. Urology (2011) 0.86
Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins. Kidney Int (2005) 0.85
Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1. Nephrol Dial Transplant (2007) 0.84
Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant (2007) 0.84
Protons in supercritical water: a multistate empirical valence bond study. J Am Chem Soc (2004) 0.82
Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol (2013) 0.80
Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients? Nephron Physiol (2010) 0.80
ESR1 promoter polymorphism is not associated with nonsyndromic cryptorchidism. Fertil Steril (2011) 0.80
Cost-effective PKHD1 genetic testing for autosomal recessive polycystic kidney disease. Pediatr Nephrol (2013) 0.78
The leucine-rich repeat-containing G protein-coupled receptor 8 gene T222P mutation does not cause cryptorchidism. J Clin Endocrinol Metab (2007) 0.78
Hydrogen bond structure and dynamics in aqueous electrolytes at ambient and supercritical conditions. J Phys Chem B (2006) 0.78
Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients. Am J Nephrol (2014) 0.77
Does the obesity survival paradox of dialysis patients differ with age? Blood Purif (2015) 0.77
Aqueous electrolytes confined within functionalized silica nanopores. J Chem Phys (2011) 0.77
[Sodium transporters and aquaporins: future renal biomarkers?]. Med Clin (Barc) (2007) 0.77
Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin Transplant (2013) 0.77
Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway. J Hepatol (2005) 0.76
Is albuminuria a marker of arterial remodeling? J Hypertens (2008) 0.76
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest (2017) 0.75
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients. Medicine (Baltimore) (2016) 0.75
Reply. J Hypertens (2017) 0.75
Protons in non-ionic aqueous reverse micelles. J Phys Chem B (2007) 0.75
Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure. J Hypertens (2017) 0.75
Excess protons in mesoscopic water-acetone nanoclusters. J Chem Phys (2012) 0.75
The management of bilateral cryptorchidism in the adult man: report of two cases. Arch Esp Urol (2014) 0.75
Free energy landscapes of sodium ions bound to DMPC-cholesterol membrane surfaces at infinite dilution. Phys Chem Chem Phys (2016) 0.75
Fitting properties from density functional theory based molecular dynamics simulations to parameterize a rigid water force field. J Chem Phys (2012) 0.75
Exploring the picosecond time domain of the solvation dynamics of coumarin 153 within beta-cyclodextrins. J Phys Chem B (2008) 0.75
Angioplasty and stent treatment of transplant renal artery stenosis. Nefrologia (2012) 0.75